RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 103 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $23,968,000 | +16.7% | 4,463,302 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $20,531,000 | +9.4% | 4,463,302 | +23.7% | 0.00% | 0.0% |
| Q4 2015 | $18,764,000 | -14.1% | 3,608,530 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $21,832,000 | -61.7% | 3,608,530 | 0.0% | 0.00% | -57.1% |
| Q2 2015 | $56,979,000 | +45.3% | 3,608,530 | 0.0% | 0.01% | +40.0% |
| Q1 2015 | $39,225,000 | +20.4% | 3,608,530 | +16.6% | 0.01% | +25.0% |
| Q4 2014 | $32,570,000 | +10.2% | 3,096,030 | +0.5% | 0.00% | 0.0% |
| Q3 2014 | $29,551,000 | -17.0% | 3,081,430 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $35,591,000 | +6.8% | 3,081,430 | -7.5% | 0.01% | 0.0% |
| Q1 2014 | $33,322,000 | -23.2% | 3,332,230 | 0.0% | 0.01% | -16.7% |
| Q4 2013 | $43,386,000 | -22.4% | 3,332,230 | -10.9% | 0.01% | -33.3% |
| Q3 2013 | $55,898,000 | +79.4% | 3,741,480 | +12.3% | 0.01% | +80.0% |
| Q2 2013 | $31,156,000 | – | 3,332,230 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|